FTDI
First Trust Direct Indexing’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,842
| Closed | -$4.04M | – | 708 |
|
|
2024
Q3 | $4.04M | Buy |
3,842
+124
| +3% | +$130K | 0.22% | 85 |
|
|
2024
Q2 | $3.91M | Buy |
3,718
+337
| +10% | +$354K | 0.24% | 80 |
|
|
2024
Q1 | $3.25M | Buy |
3,381
+97
| +3% | +$93.4K | 0.24% | 81 |
|
|
2023
Q4 | $2.88M | Buy |
3,284
+61
| +2% | +$53.6K | 0.26% | 78 |
|
|
2023
Q3 | $2.65M | Buy |
3,223
+43
| +1% | +$35.4K | 0.3% | 56 |
|
|
2023
Q2 | $2.29M | Sell |
3,180
-185
| -5% | -$133K | 0.25% | 80 |
|
|
2023
Q1 | $2.77M | Sell |
3,365
-7
| -0.2% | -$5.75K | 0.33% | 51 |
|
|
2022
Q4 | $2.43M | Buy |
3,372
+55
| +2% | +$39.7K | 0.32% | 57 |
|
|
2022
Q3 | $2.29M | Buy |
3,317
+23
| +0.7% | +$15.8K | 0.33% | 51 |
|
|
2022
Q2 | $1.95M | Sell |
3,294
-149
| -4% | -$88.1K | 0.27% | 76 |
|
|
2022
Q1 | $2.41M | Sell |
3,443
-135
| -4% | -$94.3K | 0.29% | 63 |
|
|
2021
Q4 | $2.26M | Sell |
3,578
-84
| -2% | -$53.1K | 0.29% | 65 |
|
|
2021
Q3 | $2.22M | Buy |
3,662
+237
| +7% | +$143K | 0.32% | 58 |
|
|
2021
Q2 | $1.91M | Buy |
3,425
+2,474
| +260% | +$1.38M | 0.29% | 74 |
|
|
2021
Q1 | $450K | Buy |
951
+93
| +11% | +$44K | 0.12% | 237 |
|
|
2020
Q4 | $415K | Buy |
+858
| New | +$415K | 0.11% | 229 |
|